WO2001026002A1 - Procede et systeme de fourniture d'informations relatives a la technique - Google Patents

Procede et systeme de fourniture d'informations relatives a la technique Download PDF

Info

Publication number
WO2001026002A1
WO2001026002A1 PCT/US2000/027411 US0027411W WO0126002A1 WO 2001026002 A1 WO2001026002 A1 WO 2001026002A1 US 0027411 W US0027411 W US 0027411W WO 0126002 A1 WO0126002 A1 WO 0126002A1
Authority
WO
WIPO (PCT)
Prior art keywords
technology
information
unpublished
unpublished information
confidential
Prior art date
Application number
PCT/US2000/027411
Other languages
English (en)
Inventor
Amy L. Tsui Collins
Lewis T. Williams
Original Assignee
Biolicense.Com
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biolicense.Com filed Critical Biolicense.Com
Priority to AU78572/00A priority Critical patent/AU7857200A/en
Publication of WO2001026002A1 publication Critical patent/WO2001026002A1/fr

Links

Classifications

    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q30/00—Commerce
    • G06Q30/06—Buying, selling or leasing transactions
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06F—ELECTRIC DIGITAL DATA PROCESSING
    • G06F16/00—Information retrieval; Database structures therefor; File system structures therefor
    • G06F16/90—Details of database functions independent of the retrieved data types
    • G06F16/93—Document management systems

Definitions

  • TECHNICAL FIELD This invention relates to a method and system for provision of previously unpublished and/or confidential information electronically to multiple users, where the information relates to novel technology or products undergoing development for commercialization.
  • the agreements that are generally entered into at this stage are: option agreements which confer upon an Optionee an option for an exclusive or non-exclusive license; an exclusive or non-exclusive license agreement; and or an R&D collaboration agreement, with R&D funding support to be paid by the Purchasing Organization to the Selling Organization and the Investigator.
  • licensing personnel from offices of technology transfer ("OTT") of the Selling Organizations may initiate contact with multiple potential Purchasing Organizations.
  • the Sellers typically send out one page letters to potential Purchasers providing the potential Purchasers with a short non-confidential disclosure of the invention that is available for licensing.
  • the business officers from the Selling Organizations generally have to follow-up their letters with several phone calls before catching the attention of the busy licensing personnel at Purchaser Organizations, generally taking about one, two or three months. Putting a CDA in place then takes another month or two. After parties have executed a CDA, confidential technical information is then sent to the potential Purchaser.
  • a due diligence team typically includes one or more technical experts who are familiar with the technical field, such as a cardiologist to evaluate a drug for treating heart disease.
  • the technical experts on the team may include those having expertise in different technical areas. For example, in the development of a drug for human use, the technical experts may include one or more of a research scientist, a clinician, a toxicologist, an oncologist, a pharmacologist and a scientist knowledgeable in the area of manufacture of pharmaceutical products.
  • the due diligence team can also include a regulatory expert who is knowledgeable about issues relevant to obtaining regulatory clearance for commercialization of the product; a marketing expert who is knowledgeable about issues relevant to the marketing for the product; a financial expert who is knowledgeable about issues relevant to the profitability of the development of the product.
  • the information relates to novel technology, including products.
  • the technology transfer can be in the form of an assignment or a license or an option or co-development of a product or a research collaboration or a sponsored research.
  • the information can be accessible electronically, via cable or via wireless means.
  • the system may comprise at least two levels of confidential information, the first level providing sufficient information to inform potential licensees or partners of the general nature of the technology to be licensed and the second level providing additional detail and, optionally, experimental data. It is another object of the present invention to provide a system that contains previously unpublished information, where the information is accessible to a plurality of parties.
  • a system contains a plurality of pieces of previously unpublished information, where the unpublished information is accessible electronically and is collected from at least two entities.
  • a system is provided as above, where previously unpublished information includes manuscripts, invention disclosures, unpublished patent applications, or experimental, including clinical, data.
  • the unpublished information can be an abstract or a complete document. Additional information that may be provided includes patent searches listing published and/or unpublished patents and/or patent applications that affect the patentability and/or freedom of operation of the listed technology.
  • a system is provided as above, where the information is collected from multiple entities, for example, two, three, four, five, six, seven, eight, nine or ten entities.
  • the information can also be collected from fifteen, twenty, twenty-five, thirty, forty, fifty, a hundred, a hundred fifty, two hundred or more entities.
  • a system is provided as above, where the information may be accessible electronically to multiple parties, for example, two, three, four, five, six, seven, eight, nine, ten or more parties.
  • the information can also be accessible electronically to fifteen, twenty, twenty-five, thirty, forty, fifty, a hundred, a hundred and fifty or two hundred or more parties.
  • a system is provided as above, where the information is compiled in the form of a database, which is accessible via the Internet or an Intranet.
  • the system can be housed in a server.
  • the system may also contain published information.
  • the published information can include, for example, published patent applications or issued patents or published journal or news articles or abstracts thereof.
  • a system is provided as above, where the system has a means for accepting a search term for searching the database, a means for searching the database, and/or a means for providing results of a search of the database.
  • the system includes a search engine.
  • a system that contains a means for accepting a search term and the term is selected from the following categories: a disease category, a condition category, a technology category, a product-in-development category, a date category, an institution category, a manuscript category, an invention disclosure category, a patent application category, an issued patent category, and a product candidate category.
  • a system is provided as above, where the results of a search is linked to further information, such as, more detailed textual information, or an e-mail address, or an audio-visual presentation.
  • the more detailed textual information can include, for example, a complete document or an expert's opinion on an item resulting from the search.
  • the expert's opinion can include, moreover, one or more opinions of a panel of experts.
  • a system is provided as above, where the system contains information regarding technology that is available for licensing.
  • a system is provided as above, where the technology can be computer hardware technology, computer software technology, electronic technology, communications technology, multimedia technology, satellite technology, cable technology, fiber optics technology, or wireless technology.
  • the system as provided above can include unpublished information on technologies such as one or more of those in the field of electrical engineering, mechanical engineering, chemical engineering, civil engineering, and aerospace engineering.
  • the system as provided above can include one or more technologies in the area of gene therapy, cell therapy, vaccine, diagnostics, small molecule drug discovery, ribozymes, antisense, DNA or RNA complementary molecules, gene discovery, expression, vector, purification, manufacturing, formulation, drug delivery, gene function identification, microarray, DNA or RNA or amino acid sequencing, antibody production, method of treatment, growth factor, cell differentiation, cytokine, cell receptor, and signaling.
  • the DNA or RNA complementary molecules can be made of compounds such as peptide nucleic acid and phosphoramidates. Small molecules include compounds such as troglitazones.
  • a system as above where the system includes a means for providing notification of new entries of unpublished information into the system.
  • the system further includes a means for tracking the number of parties accessing the system, the identity of each party accessing the system, and/or the search or searches conducted by a party accessing the system.
  • a system that contains a memory device and the memory device contains unpublished information that is collected from at least two entities.
  • the memory device can also contain published information.
  • a system as above contains a processor that is in communication with the memory device.
  • the processor can be configured to receive a query to conduct a search, to conduct a search, and/or to provide results of a search.
  • the processor can further be configured to provide notification of new information added to the memory device.
  • a system that contains a means for storing unpublished information, a means for receiving a query for a search, a means for conducting a search of the stored unpublished information, and/or a means for displaying results of a search, where the unpublished information includes information regarding manuscripts, patent applications, invention disclosures and/or experimental results.
  • a method that includes the steps of (a) viewing, using a computer, a listing of unpublished information, where the unpublished information is collected from at least two entities; (b) transmitting, using a computer, a query to search the listing of unpublished information; and (c) receiving, using a computer, results of the search.
  • the unpublished information can be information regarding technology that is available for licensing and can include information regarding manuscripts, patent applications, invention disclosures and/or experimental results.
  • the unpublished information can be in the form of abstracts and/or entire documents.
  • a method of obtaining confidential information on technologies for licensing purposes includes the steps of (a) submitting a query to obtain confidential information on a piece of technology that is available for licensing; (b) receiving authorization to access a restricted access confidential database to obtain the confidential information; and (c) accessing the confidential information in the database pursuant to the authorization.
  • the restricted access confidential database comprises confidential information on technologies that are available for licensing and the confidential information is collected from at least three parties.
  • a method for provision of unpublished information using a computer having the steps including: (a) creating a means for storage of unpublished information that can be searched; and (b) providing controlled access to stored unpublished information to a designated user, where the information includes unpublished information that can be manuscripts, invention disclosures and/or patent applications. Additionally, the information can include experimental results and/or published information.
  • the published information can be published articles, published patent applications and/or issued patents.
  • a system as above, where the system further includes a first template for conveyance of unpublished information.
  • the first template can include, for example, name of person submitting the unpublished information and a description of the unpublished information.
  • the first template can also include other information, for example, name of employer organization, title of person submitting information, telephone number for work, telephone number for home, cell phone number, facsimile number, e-mail address, work address, home address and/or preferred mode of communication.
  • a system as above where the system further includes a second template for conveyance of a bid.
  • the second template can include, for example, a bid to obtain an option to license the unpublished information, a bid to obtain a license to the unpublished information, a bid to sponsor a research program, a bid to collaborate in a research program, a bid to collaborate in a development program or a co-development program, and/or a bid to collaborate in co-marketing of a product, co-promotion of a product or co-commercialization.
  • the unpublished information includes experimental data on a product that is being developed as a drug for either human or animal use.
  • the product has undergone one of more of certain studies, such as an in vitro cellular study, an in vivo animal study, a toxicology study, a pharmacology study, a carcinogenicity study, a human safety study, a human dosing study, or a human efficacy study.
  • the unpublished information includes data on the product as a result of one or more studies, such as an in vitro cellular study, an in vivo animal study, a toxicology study, a pharmacology study, a carcinogenicity study, a human safety study, a human dosing study, or a human efficacy study.
  • studies such as an in vitro cellular study, an in vivo animal study, a toxicology study, a pharmacology study, a carcinogenicity study, a human safety study, a human dosing study, or a human efficacy study.
  • the unpublished information includes an expert's opinion on the technology or product available for licensing.
  • the expert's opinion can be opinion from a panel of experts.
  • the expert's opinion can be on one or more topics such as the mechanism of action of the product, the safety of the product, efficacy of the product, regulatory issues regarding the product, manufacturing issues regarding the product, toxicology issues regarding the product, carcinogenicity issues regarding the product, pharmacological issues regarding the product, marketing issues regarding the product, competitiveness issues regarding the product, or financial issues regarding the product.
  • the unpublished information includes information on a product that is in development and the product is a gene therapy product, a cell therapy product, a vaccine product, a diagnostic product, a small molecule product, a recombinant protein product, a DNA product, a RNA product, a plasmid product, a viral vector product, an antisense product, a ribozyme product, a RNA- complementary product, a DNA-complementary product, an antibody product, a formulation product, a microarray product, a growth factor product, or a cytokine product.
  • the RNA- or DNA- complementary product includes a peptide nucleic acid compound or a phosphoramidate compound.
  • the product is for treatment of one or more diseases or conditions such as: age related disease or conditions including Parkinson's,
  • Alzheimer's and macular degeneration allergy including allergic rhinitis and asthma; bone diseases or conditions including osteoporosis, fracture, and osteoarthritis; cancer including breast cancer, colon cancer, lung cancer, prostate cancer, ovarian cancer, liver cancer, pancreatic cancer, brain cancer, and lymphoma; cardiovascular diseases or conditions including angina, hypertension, congestive heart failure, arrythmia, and TMJ; gastrointestinal diseases or conditions including ulcer; genetic diseases or conditions including muscular dystrophy and ADA; hematological diseases or conditions including hemophilia, leukemia, and multiple myeloma; immune diseases or conditions including arthritis, autoimmune disease, lupus erythematosis, psoriasis, rheumatoid arthritis, and scleroderma; infectious diseases including bacterial, fungal, viral and pneumonia; liver diseases or conditions including cirrhosis, gall bladder diseases and hepatitis; metabolic diseases or conditions including diabetes, type I and type II, and obesity; neurological diseases or conditions including multiple
  • a system as above, where the system includes a memory device and processor, such as a computer, where the processor is configured to accept a question for an expert.
  • the processor can further be configured to provide notification of the expert of a pending question.
  • the processor can still further be configured to display the question for the expert.
  • the processor can also be configured to accept a response from the expert.
  • the processor can, moreover, be configured to provide notification of the expert's response, and display the expert's response.
  • the particular expert can be selected by the person submitting the question from a panel of experts listed on the website or unselected.
  • a system that includes a means for storing unpublished information and a means for allowing controlled access, for example, controlled by a password login means, to the stored unpublished information.
  • a method that includes the steps of accessing, using a computer, a website that displays unpublished information as above; and viewing the website.
  • a method as above where the method further includes the step of viewing an expert's opinion on the unpublished information.
  • FIGURES A- ID depict representative disease categories and subcategories for use with the invention.
  • Figure 2 shows representative technology categories for use with the invention.
  • Accessibility of the unpublished information to "at least two parties” excludes a situation in which one individual within an organization creates a database for his or her own personal use or for the use of others in the same or affiliated organization in which that individual works. In this context, all individuals within one organization, company, institution or affiliates thereof are considered one party. The "at least two parties” must be parties who are not affiliated with each other in any sense. Further, “accessibility" of information also means that the information is available upon demand, for example, of a first party and does not require an affirmative action on the part of the second party who is in possession of the information to send the information to the first party upon request by the first party, for example, as in sending information by e-mail.
  • Entity shall mean an academic institution, hospital, research institution, company, organization or an individual within such.
  • an entity can be an institution and all individuals within that institution, for example if all the individuals within the institution are obligated by agreement to assign their inventions to the institution.
  • An example is a university with multiple campuses, in which all employees of the university, regardless of campus, are considered as one entity, because employees on all the campuses are required to assign their inventions, developed by virtue of their employment, to the university.
  • individuals working there may not be required to assign their inventions to the university, and may own the inventions in their own right. In such instances, each such individual is considered as one entity.
  • invention disclosure means any writing capturing a new idea or a new invention.
  • the writing may be in the form of notes, for example, as recorded in one or more inventors' laboratory notebooks, or may be on an Invention Disclosure form or may be a manuscript.
  • a "Manuscript” is a document that is prepared for submission to a journal or book editor for publication or for submission to an organization for presentation at a scientific meeting, including submission for poster presentations.
  • Previous unpublished information means information that has been previously held in confidence and has not been previously publicly disclosed.
  • the system of the present invention can contain unpublished information pertaining to manuscripts or invention disclosures or unpublished patent applications.
  • the manuscripts can contain information submitted or to be submitted to a journal for publication.
  • the manuscripts can also contain information submitted or to be submitted to meeting organizers for presentation at meetings.
  • the presentation can be an oral presentation or a poster presentation.
  • the meetings can be scientific meetings.
  • the unpublished information can also pertain to unpublished experimental results.
  • Experimental results can be results from in vitro studies, such as cellular studies and assays or from in vivo studies, such as animal studies for studying toxicology, pharmacology and carcinogenicity. Experimental results can also be results of clinical trials, for example, in humans for drugs for human use or in animals, for drugs for animal use.
  • Clinical trials include human safety trials, typically referred to as Phase I studies, or human dosing trials, typically referred to as Phase II studies, or human efficacy trials, typically referred to as Phase III studies.
  • the studies can be combined.
  • Phase I/II study in which both safety and dosing data are collected.
  • Phase II/III study in which dosing and efficacy data are collected.
  • the system can contain published information such as published patent applications, issued patents or published scientific or news articles. Further, the information in the system can be abstracts or can be entire or complete documents.
  • the unpublished information contains novel subject matter that has not been previously publicly disclosed.
  • the novel subject matter has not been previously claimed or described in an unpublished patent application.
  • the system may provide, with reference to a particular technology, a patent search that lists published and/or unpublished patents and/or patent applications that affect the patentability and/or freedom of operation of the listed technology. For example, if a license to a dominating patent is needed to practice the particular invention in question, such a dominating patent may be appended to the listed technology.
  • the confidential patent system contains confidential information on unpublished information, such as unpublished invention disclosures and/or patent applications.
  • the public system contains information on published patents and patent applications such as those directed to publicly known technologies.
  • access to the patent information may be controlled. For example, before a viewer can access the patent information, the viewer may need to agree to pay a fee.
  • the payment can be based on a per view basis, e.g., one payment for viewing the information related to one technology, such as patent information relating to HER2 antibodies, for example.
  • the system may include information regarding licensees of a particular technology.
  • the identification of licensees may be based on published information, such as from filings with the SEC, or information published by institutions such as universities. This information may be used, for example, by a company seeking a license to technology that has already been exclusively licensed to another entity. Thus, the company may wish to obtain a license from the existing licensee.
  • the information that is accessible through the system of the present invention can be information that is collected from three entities, four entities, five entities, six entities, seven entities, eight entities, nine entities, or ten entities.
  • the information is collected from about eleven to fifteen entities. More preferably, the information is collected from about sixteen to twenty entities. Most preferably, the information is collected from about twenty-one to twenty-five entities.
  • the number of entities can be greater than twenty- five. More preferably, the number is greater than thirty. Most preferably, the number is greater than forty or fifty or a hundred and fifty or two hundred.
  • the information that is collected is accessible to at least two parties.
  • the information is accessible to about eleven to fifteen parties. More preferably, the information is accessible to about sixteen to twenty parties. Most preferably, the information is accessible to about twenty-one to twenty-five parties.
  • the number of parties can be greater than twenty-five. More preferably, the number is greater than thirty. Most preferably, the number is greater than forty.
  • the information that is collected can be compiled, for example, in the form of a database.
  • This database can be made accessible to multiple parties via the Internet or via Intranet services.
  • the database can be housed in a server or can be housed with an Internet Service Provider ("ISP").
  • ISP Internet Service Provider
  • the manner in which the database is set up is conventional in the art.
  • an independent contractor can be hired to construct the desired website, database, and search engine and select the appropriate ISP and utilize the appropriate encryption/decryption technology or security to implement the present invention.
  • a system can be set up or constructed in such a way as to provide a means for accepting a search term, a means for searching the database, a means for providing results of a search, for example, by listing one and all items that meet the search criteria.
  • an item can be linked to further or more detailed information about the item, which can be textual material and/or an e-mail address, for example, the e-mail address of the institution providing the information or the invention of the information that is listed in the result, and/or the item can be linked to an audio-visual presentation, such as one given by the inventor of the information listed.
  • the further information about the item resulting from a search can be expert's opinion on the subject.
  • the expert's opinion can include opinion of one or more experts.
  • the skilled contractor can also create a means for providing notification of addition of new information into the database.
  • the skilled contractor can also create a means for keeping track of the identity of a party who is accessing or has accessed the database, the total number and identification of parties who have accessed a given site in the database, for example, who has accessed information provided by a particular university.
  • the skilled contractor can further provide a means for tracking the click stream of a party accessing the database so as to determine the subject areas of interest to a particular party.
  • the search term can be any terms conventionally used by persons skilled in the art to conduct searches for the technology sought. Further, the search term can be selected a list of categories including but not limited to: a disease category, a condition category, a technology category, a product category, a product-in- development category, a date category, an institution category, a manuscript category, an invention disclosure category, a patent application category, an issued patent category, a product candidate category, and a miscellaneous category.
  • Each category can be further subdivided into subcategories.
  • the categorization is conventional in the art.
  • the disease category can be subdivided into diseases affecting certain organs or diseases arising from different causes.
  • Representative disease categories and subcategories are shown in Figures 1 A- 1D.
  • disease categories can include, but is not limited to the following: cardiovascular diseases, infectious diseases, cancer, autoimmune diseases, inflammatory diseases, central nervous system disease, neuronal disorders, metabolic disorders such as diabetes, diseases of the aged, and a miscellaneous category.
  • cardiovascular diseases can include ischemia and myocardial infarction.
  • Central nervous system disease can include Alzheimer's disease and Parkinson's disease.
  • Infectious diseases can include infections by bacteria, viruses or fungi.
  • Further subcategorization can include, for example, in the viral infectious disease category: hepatitis B infection ("HBN”), hepatitis C infection (“HCN”), and human immunodeficiency virus infection (“HIN”).
  • HBN hepatitis B infection
  • HCN hepatitis C infection
  • HIN human immunodeficiency virus infection
  • Cancer can include, for example, brain cancer, breast cancer, lung cancer, prostate cancer, ovarian cancer, colon cancer, liver cancer, pancreatic cancer, and gastric cancer.
  • Autoimmune diseases can include, for example, lupus erythematosis.
  • Inflammatory disease can include, for example, osteoarthritis, inflammatory bowel syndrome, and psoriasis. These categories or subcategories are not intended to be mutually exclusive of each other. A given disease may fall into several different categories or subcategories. For example, stroke may fall within the category or subcategory of cardiovascular disease as well as the category or subcategory of central nervous system disease or disorder as traumatic brain injury. Osteoarthritis may fall within the category or subcategory of cartilage disease or inflammatory disease.
  • the unpublished information contains technology or products that are available for licensing to others.
  • the technology can be any technology including those in the computer and communications area, those in the biotech and pharmaceutical area, and those in the engineering and petroleum area.
  • the technology that is available for licensing in the computer and communications area can include but is not limited to: computer hardware technology, computer software technology, electronic technology, communications technology, multimedia technology, satellite technology, cable technology, and wireless technology.
  • the technology that is available for licensing in the engineering and petroleum area can include but is not limited to electrical engineering technology, mechanical engineering technology, chemical engineering technology, civil engineering technology, petroleum technology, and aerospace engineering technology.
  • the technology that is available for licensing in the biotech and pharmaceutical area can include but is not limited to technology applicable to one or more of the following areas: gene therapy, cell therapy, vaccine, diagnostics, small molecule drug discovery, gene discovery, expression, vector, purification, manufacturing, formulation, drug delivery, gene function identification, microarray, sequencing, separation, antibody, ribozymes, antisense, RNA-complementary molecules, DNA-complementary molecules, method of treatment, growth factor, cell differentiation, cytokine, cell receptor, and signaling. Representative biotech and pharmaceutical technology categories are shown in Figure 2.
  • RNA-complementary molecules and DNA-complementary molecules include peptide nucleic acids, and compounds of the family of phosphoramidates.
  • the system utilizes a computer and/or a memory device.
  • the processor can be configured to receive a query for conducting a search.
  • the system of the present invention is configured such that the processor can effect a search of the database based on a query, and generate results of a search in a display format, such as a list of items meeting the criteria of the query.
  • the system contains and includes but is not limited to the following components: (a) a means for storing unpublished information; (b) a means for receiving a query for a search; (c) a means for conducting a search of the stored unpublished information; and (d) a means for displaying results of a search, where the unpublished information comprises information such as manuscripts, patent applications, and invention disclosures.
  • the system can include published information. Further additionally, the system can contain either published or unpublished experimental results.
  • a method contains and includes but is not limited to the steps of: (a) viewing, using a computer, a listing of unpublished information, wherein the unpublished information is collected from at least three entities; (b) transmitting, using a computer, a query to search the listing of unpublished information; and (c) receiving, using a computer, results of the search.
  • the system can include published information.
  • a method of using a computer to search for technology available for licensing including but not limited to the steps of: (a) transmitting, using a computer, a search term for searching a database; and (b) receiving, using a computer, results of the search, where the database contains and includes but is not limited to unpublished information.
  • the unpublished information can be manuscripts, invention disclosures and/or patent applications.
  • the system can include published information.
  • a method of providing unpublished information using a computer comprising the steps of: (a) creating a means for storage of unpublished information that can be searched; and (b) providing access of stored unpublished information to a designated user, where the unpublished information comprises information containing and including but is not limited to manuscripts, invention disclosures, and/or patent applications.
  • the system can include published information.
  • the method and system includes creating and installing a firewall to prevent any non-designated user from accessing the stored unpublished information.
  • This method and system can be created by persons skilled in the art.
  • One convenient method of practicing the subject invention is by allowing subscribers access to the database by using a website.
  • subscribers may access the website using, for example, the Internet.
  • the website may comprise at least two levels of confidential information, the first level providing sufficient information to inform potential licensees or partners of the general nature of the technology to be licensed and the second level providing additional detail and, optionally, experimental data.
  • the use of multiple levels of confidential information provides several advantages. For example, universities and companies tend to solicit interest in their technologies by sending non-confidential information about their technologies to potential licensees or potential partners. Very often, the non-confidential information is insufficient to inform those people evaluating technologies ("Evaluators") exactly as to the nature of the technologies.
  • a first level of information might be "a small molecule inhibitor of PI3 kinase that inhibits tumor metastases when injected intravenously into mice.”
  • a potential licensee may consider whether or not they want to look at the more detailed second level confidential information and run the risk of perhaps being accused of misappropriating another party's trade secrets.
  • the second level of confidential information serves to provide a more detailed description of the technology and, optionally, some experimental data.
  • the second level of confidential information may have, for example, the family of inhibitory compounds.
  • there is a third level of confidential information either available on the Internet or by a hard paper copy, which contains the chemical structures of the specific compounds that have the inhibitory effect.
  • Another example of a first level confidential information can be
  • a second level confidential information in this regard can be experimental data showing enhancement and suppression of inflammatory response using the protein and an antibody to the protein, respectively.
  • a series of questions can be provided between the first level of confidential information and the second level of confidential information.
  • viewers may be required to answer questions regarding whether they know of any internal research in the area of the technology being viewed, and whether they are certain that they want to proceed to the second level.
  • the website can be configured such that the user is informed of new technologies listed since the last time that user visited the website. Furthermore, a message can be sent to the subscriber when new technology is listed which is relevant to the subscriber's field of interest. This can be done, almost immediately, using electronic mail or by other electronic transmissions.
  • the information can be provided as different categories and subcategories as described above and as depicted in the figures herein.
  • the searcher is able to combine key words from different fields, for example, a search for a growth factor for treatment of obesity (a metabolic disease) or a search for a cytokine discovered by a researcher at a particular university.
  • Search results can be ordered chronologically and/or alphabetically by, for example, research institution.
  • the website can be structured to allow a user access to more detailed information about the technology, such as by accessing further information and/or an audio-visual presentation of a chosen technology by the inventor or entity providing of the technology.
  • the invention may also be configured to allow the user to send questions via electronic mail to appropriate persons, such as the inventor or entity providing the technology or experts available as consultants regarding that technology.
  • appropriate persons such as the inventor or entity providing the technology or experts available as consultants regarding that technology.
  • the website can then post frequently asked questions and answers, as well as an Expert Opinion pages.
  • an entity may obtain access to the confidential database of technology information by being a subscriber who would pay a subscription fee and obtain access to the entire database of confidential information based on authorized access, such as by use of a password and user identification number ("ID").
  • ID user identification number
  • Such user's access may be monitored whenever user accesses the confidential information of any party.
  • user can log into the confidential website using the user ID and password.
  • an entity may obtain access to the confidential information residing in the confidential database on a case by case basis, such as, by first contacting the group or person in charge of authorizing access to the confidential site, for example, by E-mail or by submitting a request such as one that may be available on a non-confidential page of a website, and receiving authorization to access the confidential information, such as by obtaining a password and user ID.
  • the entity desiring confidential information may request the information directly, such as by E-mail, or via the website as above, and the information may be sent to the requesting party electronically or by fax or by mail.
  • an entity may prefer to send a query or request for a search to the supplier of the database. The supplier can then do a search of the database for technologies of interest to the entity. In this embodiment of the invention, the entity does not access the database directly.
  • the click stream of users can be monitored to identify who and how many users access the different levels of the website.
  • a report can be generated periodically, e.g., monthly, for each information provider, the report including, for example, how many companies accessed information regarding the information provider's technology, as well as a description of the companies and what level of detail these companies seek.
  • a report can also be generated periodically for the purchasing entity with information such as the number of employees that accessed the database and regarding the fields probed.
  • a website can further be constructed such that the person or entity providing the unpublished information on a technology can access the website and view that technology and any publicly accessible information, but cannot access the website and view other person's or entity's technology without being an authorized subscriber to the website.
  • a database for storing information regarding licensing terms for benchmarking purposes can also be developed.
  • databases and websites may be designed using techniques known in the art. For example, persons skilled in the art for constructing websites and databases can be found at known companies, for example, those in Silicon Valley in California, such as Oracle, Inc. Others can be found via the Internet using search engines such as Yahoo.com and Google.com. Further encryption software is currently available in the marketplace. An easy software to use is PGP (Pretty Good Privacy) that is available from MIT and can be downloaded from the Internet. In one embodiment of the present invention, a research scientist (hereafter
  • Principal Investigator or an OTT personnel of an Information Provider organization can transfer confidential information for input into the system of the present invention via e-mail using an encryption/decryption software, such as PGP software, to scramble the message.
  • the Principal Investigator or OTT personnel can provide addressee of the e-mail message a key for unscrambling the message.
  • Principal Investigator of OTT personnel may be given password access to a secured system via Intranet.
  • the Principal Investigator and the OTT personnel may be given access to a website (hereafter a "Designated Website") to fill in a template for conveyance of the confidential, previously unpublished information.
  • the template can be structured so as to allow the Principal Investigator or OTT personnel to provide one or more of the following information: Name of Principal Investigator, Title, Organization, Telephone Number for Work, Telephone Number for Home, Cell Phone Number, Work Address, E-Mail Address, Facsimile Number, and Preferred Mode of Communication.
  • the system of the present invention includes a compilation of information on contacts, including Principal Investigators and OTT personnel.
  • the system includes a template structured to allow Principal Investigator or OTT personnel to indicate whether the unpublished information being submitted is a Manuscript for submission to a journal for publication or for submission to meeting organizers for presentation at a meeting. If the unpublished information is intended to be submitted to a journal for publication, the template includes an area for indication of the Name of the Journal, and/or Intended Date of submission of Manuscript. If the unpublished information is intended for submission to meeting organizers for presentation at a meeting, the template includes an area for specification of the Name of the Meeting, the Location of the Meeting, the Date of the Meeting, the Expected Date of Publication of Abstracts for the Meeting, the Deadline for submission of Abstract, and/or the Intended Date of submission of Abstract.
  • the system of the present invention can include the capability of sending an automatic response to a Principal Investigator and/or OTT personnel, acknowledging receipt of confidential information transmitted by the Principal Investigator or OTT personnel.
  • the automatic response can include a message indicating the expected date of the next action to be taken.
  • the system of the present invention also includes a listing of all agreements executed through use of the system and the financial terms of such agreements.
  • this listing is searchable by name of Selling institution, name of Buying institution, date of execution, technology or disease area of the subject matter of the agreements.
  • a message appears when an authorized party accesses the system, the message alerting the party to the confidential nature of the materials the party is about to see.
  • the message can read: "You are about to view confidential and/or proprietary subject matter.” Additional language may be added, for example: "Viewing of this subject matter is subject to terms and conditions of a Confidential Disclosure Agreement which your employer has signed and to which you are bound.”
  • a message appears on the system, warning the party of possible issue of contamination of ideas, and/or not to access the detailed information if there is any concern about such possible contamination.
  • the message can read: "You are reminded that the information you are about to see is confidential and proprietary. If your company or you are engaged in research in the same or similar area, please remember that you are prohibited from using the information or knowledge gained herein for you or your company's benefit without first obtaining a license to use such information.”
  • the system affords a party accessing the system to order a copy of the unpublished information.
  • the system can contain a page seeking information as to how the party wishes the information to be sent, for example, by facsimile, by first class mail or by courier, such as Federal Express or United Parcel Service or Airborne Express.
  • the system of the present invention can include a page to allow a party accessing the system to indicate whether the party is interested in obtaining an option to license the technology, or a license to the technology, or in supporting a research and development collaboration ("R&D Collaboration"), or in sponsoring a research program, or in co-development of a product, or in co-commercialization of a product, or in submitting a bid, obtaining further information, seeking answers to questions, or is not interested.
  • R&D Collaboration research and development collaboration
  • the present system can also include a set of minimum financial terms for licensing the technology, for granting an option to license the technology and/or for supporting a R&D Collaboration.
  • the system can include a template for a bid or an offer that the party accessing the system can fill in and submit.
  • the template can include one or more of the following: Option Fee, Option Term, Option Extension or Renewal Fee, License Fee, License Term, License Maintenance Fee, prepaid Royalties, Patent Preparation and Filing Expenses, Royalties (in percent of Net Sales), R&D Collaboration Term, R&D Collaboration Support, and Milestone Payments.
  • the Milestone Payments can include one or more of the following: First Issuance of a U.S.
  • Patent First Issuance of a European Patent, First Issuance of a Japanese Patent, First Issuance of a Patent in any one of the ROW (Rest of World) countries, Initiation of Animal Studies, Naming of a Lead Molecule, Filing of a First Investigational New Drug Application (“IND”) or equivalent in any country, Initiation of a First Phase I or Safety or equivalent Clinical Study in Humans in any country, Initiation of a First Phase II or Dosing or equivalent Clinical Study in Humans in any country, Initiation of a First Phase III or Efficacy or equivalent Clinical Study in Humans in any country, Filing of a First New Drug Application (“NDA”) or Product License Application (“PLA”) or equivalent in any country, First Regulatory Approval for Marketing in any country, Regulatory Approval for Marketing in a second country, Regulatory Approval for Marketing in a third country, Regulatory Approval for Marketing in a fourth country, etc.
  • NDA First New Drug Application
  • the bidding process may include one or two or more rounds of bidding before a license or option is granted.
  • the system contains unpublished information that includes experimental data on a product or a product-in-development (collectively, "Product Opportunity") that is undergoing development as a drug for human or animal use.
  • the experimental data can be any data that is helpful in the evaluation of the Product Opportunity.
  • such data can include one or more of the following studies: in vitro studies, such as cellular studies or assay, in vivo animal studies, animal safety studies, animal efficacy studies, toxicology studies, carcinogenicity studies, pharmacology studies, human safety studies, human dosing studies, and human efficacy studies.
  • the system contains expert's opinion on a technology or a Product Opportunity.
  • the expert's opinion can be the opinion of one or more experts in the field.
  • the expert can be anyone having expertise in an area relevant to the technology that is available for licensing.
  • the expert can be someone having expertise in the development and commercialization of a drug for human or animal use.
  • the expert can be a research scientist, a clinician, a toxicologist, a pharmacologist, an oncologist, a person knowledgeable in the area of manufacturing, a regulatory expert knowledgeable in the area of regulatory approval for commercialization of drug, a financial expert knowledgeable in the financial risk/cost/benefit analyses of developing a product for commercialization, a marketing expert knowledgeable in the area of marketing and competitiveness of the technology or Product Opportunity.
  • the Product Opportunity of the present invention includes any product that is useful for the diagnosis, prophylaxis and treatment of human and animal diseases and conditions.
  • the Product Opportunity can pertain to the following products: a gene therapy product, a cell therapy product, a vaccine product, a diagnostic product, a small molecule therapeutic product, a recombinant protein product, a DNA product, a viral vector, a formulation product, a microa ⁇ ay product, an antibody product, a growth factor, a cytokine, a DNA-complementary product, a RNA-complementary product, a ribozyme, and an antisense product.
  • the DNA- or RNA-complementary product can be a peptide nucleic acid or a phosphoramidate or similar compound.
  • the system can accept a question and can notify a person, such as an expert, or the system administrator of the arrival of a question, for example, by e-mail.
  • the system can display the question and accept a response from a person, such as the expert and system administrator.
  • the system can additionally notify the person sending the question of the arrival of a response.
  • the system can further display the response.
  • Example 1 This is an example of a proposed bid with an independent contractor for construction of a website of the present invention. Services that can be provided are:
  • a database can be created to store information on licensing terms, and formatted for a wide variety of standard formats. 22. Information Providers will be able to see what confidential information of theirs has been posted on the site, but not what confidential information others have supplied. All confidential information will remain secure.
  • An automatic bidding system will be integrated into the site, a system where members can fill out a form to bid on a technology and have their bid both posted, if desired, and emailed to a site administrator address.
  • Closing bid dates will be generated differently for different levels of memberships, and a listing of bid dates will be kept automatically updated.

Landscapes

  • Engineering & Computer Science (AREA)
  • Business, Economics & Management (AREA)
  • Theoretical Computer Science (AREA)
  • Accounting & Taxation (AREA)
  • General Business, Economics & Management (AREA)
  • Databases & Information Systems (AREA)
  • Physics & Mathematics (AREA)
  • Finance (AREA)
  • General Physics & Mathematics (AREA)
  • Data Mining & Analysis (AREA)
  • General Engineering & Computer Science (AREA)
  • Development Economics (AREA)
  • Economics (AREA)
  • Marketing (AREA)
  • Strategic Management (AREA)
  • Storage Device Security (AREA)

Abstract

L'invention concerne des systèmes et des procédés de fourniture d'une source consultable et d'accès, électroniquement par câble ou sans fil, à des informations jusque là confidentielles ou non publiées, relatives à la technique, dont des produits susceptibles d'être brevetés. Ces informations sont collectées parmi plusieurs entités et peuvent être rendues accessibles à plusieurs parties. L'invention porte également sur des systèmes et des procédés relatifs à des informations sur une technique nouvelle, non publiées et accessibles par un site Web protégé, par exemple, protégé par un mot de passe, permettant d'assurer la protection des informations stockées, l'accès étant interdit aux personnes non autorisées. L'invention se rapporte encore à des systèmes et à des procédés permettant de donner l'opinion d'un expert sur une technique nouvelle, et de présenter en ligne une offre pour une technique.
PCT/US2000/027411 1999-10-05 2000-10-03 Procede et systeme de fourniture d'informations relatives a la technique WO2001026002A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU78572/00A AU7857200A (en) 1999-10-05 2000-10-03 Method and system for provision of information on technology

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US60/157,799 1999-10-05
US60/159,626 1999-10-14
US42141899A 1999-10-19 1999-10-19
US09/421,418 1999-10-19
US60/165,396 1999-11-15
US60/214,052 2000-06-26

Publications (1)

Publication Number Publication Date
WO2001026002A1 true WO2001026002A1 (fr) 2001-04-12

Family

ID=23670429

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/027411 WO2001026002A1 (fr) 1999-10-05 2000-10-03 Procede et systeme de fourniture d'informations relatives a la technique

Country Status (1)

Country Link
WO (1) WO2001026002A1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2368673A (en) * 2000-04-14 2002-05-08 Ford Global Tech Inc Online invention disclosure system with search function
US7069592B2 (en) 2000-04-26 2006-06-27 Ford Global Technologies, Llc Web-based document system
US7376635B1 (en) 2000-07-21 2008-05-20 Ford Global Technologies, Llc Theme-based system and method for classifying documents
US20150295933A1 (en) * 2014-04-14 2015-10-15 Moshe Rogosnitzky System and Method for Providing an Early Stage Invention Database

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4827508A (en) * 1986-10-14 1989-05-02 Personal Library Software, Inc. Database usage metering and protection system and method
US4992940A (en) * 1989-03-13 1991-02-12 H-Renee, Incorporated System and method for automated selection of equipment for purchase through input of user desired specifications
US5493677A (en) * 1994-06-08 1996-02-20 Systems Research & Applications Corporation Generation, archiving, and retrieval of digital images with evoked suggestion-set captions and natural language interface
EP0766165A2 (fr) * 1995-08-31 1997-04-02 Fujitsu Limited Système de notification de licenses
US5629980A (en) * 1994-11-23 1997-05-13 Xerox Corporation System for controlling the distribution and use of digital works
US5896298A (en) * 1997-08-08 1999-04-20 Carreker-Antinori, Inc. System and method for providing central notification of issued items

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4827508A (en) * 1986-10-14 1989-05-02 Personal Library Software, Inc. Database usage metering and protection system and method
US4992940A (en) * 1989-03-13 1991-02-12 H-Renee, Incorporated System and method for automated selection of equipment for purchase through input of user desired specifications
US5493677A (en) * 1994-06-08 1996-02-20 Systems Research & Applications Corporation Generation, archiving, and retrieval of digital images with evoked suggestion-set captions and natural language interface
US5629980A (en) * 1994-11-23 1997-05-13 Xerox Corporation System for controlling the distribution and use of digital works
EP0766165A2 (fr) * 1995-08-31 1997-04-02 Fujitsu Limited Système de notification de licenses
US5896298A (en) * 1997-08-08 1999-04-20 Carreker-Antinori, Inc. System and method for providing central notification of issued items

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GALE GROUP NEWSLETTER [online] STILLMAN: "Behind the firewall: Newsletter content can thrive in enterprise networks", XP002936818, Database accession no. 04593850 *
THE NEWSLETTER ON NEWSLETTERS, vol. 37, no. 3, 15 February 2000 (2000-02-15), pages 35 - 36 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2368673A (en) * 2000-04-14 2002-05-08 Ford Global Tech Inc Online invention disclosure system with search function
US7069592B2 (en) 2000-04-26 2006-06-27 Ford Global Technologies, Llc Web-based document system
US7376635B1 (en) 2000-07-21 2008-05-20 Ford Global Technologies, Llc Theme-based system and method for classifying documents
US20150295933A1 (en) * 2014-04-14 2015-10-15 Moshe Rogosnitzky System and Method for Providing an Early Stage Invention Database

Similar Documents

Publication Publication Date Title
US20080065514A1 (en) Personal inventory management and item exchange network
US20090192941A1 (en) Digital marketplace for healthcare data
US20090024534A1 (en) Online marketplace for intellectual property
WO2009086266A1 (fr) Utilisation d'informations de réseaux sociaux
WO2006052610A2 (fr) Service de mise en correspondance de professionnels
US20030097305A1 (en) Custom synthesis pharmaceutical electronic commerce system and method
US20100023424A1 (en) Online marketplace for intellectual property
US20120047021A1 (en) System and method for marketing business leads with white papers
US20070282663A1 (en) Group purchase program systems and methods
US20040049444A1 (en) Trade supporting method and system
Kim et al. Developing a digital library model for virtual universities in Korea: Current state and prospective model
WO2001026002A1 (fr) Procede et systeme de fourniture d'informations relatives a la technique
Spulber The map of commerce: Internet search, competition, and the circular flow of information
Robinson Open access: the view of a commercial publisher
Boss How to plan and implement a library portal
Best Following the money across the landscape of sociology journals
Tobia et al. Electronic Journals
KR20130113569A (ko) 온라인 이미지거래 서비스 장치 및 그 방법
US8595113B1 (en) Facility for the finding, acquisition, and maintenance of intellectual property assets
Sitko et al. E-journal management systems: trends, trials, and trade-offs
Calsamiglia et al. Managing Congestion in Two-Sided Platforms: The Case of Online Rentals
US20040267609A1 (en) Methods and systems for specifying and distributing consumer information
Wiley et al. The state of ILL in the state of IL: the Illinois Interlibrary Loan Assessment Project
Delaney Buy, Borrow, or Steal: Patterns in Searching for Scholarly Literature
JP2001273412A (ja) 会員制のマルチ支援システム

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP